No Data
No Data
No Data
No Data
No Data
Cracking The Code: Understanding Analyst Reviews For Tandem Diabetes Care
Ratings for Tandem Diabetes Care (NASDAQ:TNDM) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The following table encapsulates their recent
Benzinga15:01 ET
Express News | Tandem Diabetes Care Shares Are Trading Higher. Stifel Maintained Its Buy Rating on the Stock and Raised Its PT Rom $37 to $40
Moomoo 24/713:12 ET
Tandem Diabetes Care Is Maintained at Buy by Stifel
Tandem Diabetes Care Is Maintained at Buy by Stifel
Dow Jones13:12 ET
Express News | Stifel Maintains Buy on Tandem Diabetes Care, Raises Price Target to $40
Moomoo 24/713:01 ET
Express News | Tandem Diabetes Care Inc : Stifel Raises Target Price to $40 From $37
Moomoo 24/7Apr 23 06:52 ET
Insider Stock Buying Reaches US$725.5k On Tandem Diabetes Care
Usually, when one insider buys stock, it might not be a monumental event.
Simply Wall StApr 16 07:12 ET
No Data
No Data